Lisette Hilton
Lisette Hilton, president of Words Come Alive, has written about health care, the science and business of medicine, fitness and wellness for 25 years. Visit
Achieving the lower eyelid ideal
Achieving the lower eyelid ideal
One surgeon shares nuances of a combination treatment to rejuvenate the lower lid-cheek junction.
Bundle up to boost holiday sales
From skin care to gift certificates, experts weigh in on the best ways to boost business during the holiday season.
Mathematical model may predict PCa tumor growth, evolution
The novel tool could result in earlier prostate cancer diagnoses and less invasive testing, although a prostate cancer expert cautioned that the model makes multiple assumptions and has not been validated.
Nomogram helps predict biochemical failure risk post RP
Use of the nomogram, along with factors such as PSA level and family history, is a reliable, useful tool for helping urologists and their patients make better treatment decisions, says the author of a recent study.
The FACE-Q Eye Module
It’s a new tool that gathers patient feedback to communicate your cosmetic eye surgery prowess.
Rethinking complete platysma transection
Research suggests this aggressive approach comes up short on long-term results. Two experts offer alternative approaches.
Body hair transplants for baldness
It’s a viable option, according to experts, but the use of body hair to treat baldness requires careful patient selection and strategic technique.
Immunotherapies move toward FDA approval for urothelial Ca
Two late-stage immunotherapy drugs for the treatment of urothelial carcinoma reach regulatory, research milestones.
Next-gen sequencing panel for renal Ca earns CLIA approval
The genomic profiling tool distinguishes among the dominant three malignant and one benign renal cancer subtypes.
Study: More evidence of T therapy’s safety in some PCa patients
Testosterone therapy in hypogonadal men with prostate cancer who have had definitive treatment and in those on surveillance appears to be safe, according to a new study.